IOSP shows a technically confirmed breakout with four consecutive earnings beats and an attractive forward valuation at 13.9x earnings — but the stock is within 1.1% of its resistance target at a 0.25-to-1 risk/reward, free cash flow converts at only 11% of net income, and options traders are positioned defensively; the setup warrants patience for a better entry rather than action at the current price.
Thesis pillars
- Attractive Forward Valuation→Stable
- Price At Resistance Poor Entry Geometry→Stable
- Technical Breakout Momentum→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 18, 2026
Innospec Inc. (IOSP) Stock Analysis
Breakout setup
Basic Materials · Specialty Chemicals
Sell if holding. Analyst target reached at $100.70 — A.R:R is negative (-2.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: ethylene single source (German operations) (4.0%).
Innospec develops, manufactures, and supplies specialty chemicals through three segments — Performance Chemicals, Fuel Specialties, and Oilfield Services — serving customers in the Americas, Europe, Middle East, Africa, and Asia-Pacific with approximately 2,450 employees in 22... Read more
Sell if holding. Analyst target reached at $100.70 — A.R:R is negative (-2.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: ethylene single source (German operations) (4.0%). Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Score 6.2/10, moderate confidence.
Passes 5/8 gates (positive momentum, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 5d<=7d. Suitability: aggressive.
About Innospec Inc.
About Innospec Inc.
Innospec operates three specialty chemicals segments — Performance Chemicals, Fuel Specialties, and Oilfield Services — selling to customers across the Americas, Europe, the Middle East, Africa, and Asia-Pacific from approximately 2,450 employees in 22 countries. R&D expenditures of $51.0 million in 2025, $56.5 million in 2024, and $49.0 million in 2023 support new formulations including mild surfactants in Performance Chemicals, emission-reducing detergents in Fuel Specialties, and friction modifiers and biocide formulations in Oilfield Services.
Innospec earns revenue by selling specialty chemical products to national and multinational oil companies, fuel marketers, fuel terminals, marine lines, large personal care and home care manufacturers, and exploration & production companies operating principally in the Americas and the Middle East. Key raw material purchases — oleochemicals, cetane number improvers, ethylene, solvents, amines, alcohols, and polyacrylamides — represent a substantial portion of variable manufacturing costs; most are available from multiple sources, but ethylene for one German facility arrives via a dedicated pipeline that functions as a single source, supplying products representing approximately 4% of group sales. Within Fuel Specialties, the company holds the sole position as producer of tetraethyl lead for aviation gasoline, marketed as the AvGas product line. Oilfield Services margins are sensitive to oil and gas exploration and production activity, which is subject to commodity price trends.
Show full overview
The AvGas product line faces a dated regulatory transition: a U.S. industry coalition (EAGLE) has stated an aim to eliminate lead emissions from general aviation by the end of 2030, with an Alaskan derogation extending to the end of 2032. In the EU, three users obtained REACH Authorization permitting continued use of TEL until the end of April 2032. If a suitable unleaded replacement is identified and lead prohibition is implemented, Innospec's future operating income and cash flows from the AvGas line could be adversely impacted — though the 10-K notes no currently available alternative exists.
See also: Basic Materials · Specialty Chemicals
From Innospec Inc.'s most recent 10-K filing, extracted June 10, 2026.
Recent developments
updated 2026-10-29Recent Developments — Innospec Inc.
Latest news
- NEWS Innospec Inc (IOSP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey — TradingKey neutral
- NEWS Innospec Q1 Earnings Beat Estimates, Sales Rise Y/Y On FX Tailwinds - TradingView — TradingView positive
- NEWS Innospec Q2 2026 Earnings Call Transcript - MarketBeat — MarketBeat neutral
- NEWS Innospec Q2 Earnings Call Highlights - Yahoo Finance — Yahoo Finance neutral
- NEWS Innospec Q2 Earnings Call Highlights - finance.yahoo.com — finance.yahoo.com neutral
Generated 2026-10-29T11:48:40Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSupplierethylene single source (German operations)4.0%10-K Item 1: 'we source ethylene for our German operations via a direct pipeline, making it effectively a single source ... products representing approximately 4% of Innospec's sales'
Material Events(8-K, last 90d)
- 2026-06-04Item 5.02LOWBoard expanded from 7 to 8 directors; Shelley Bausch appointed Class II director effective July 1, 2026, also to serve on Audit Committee. Standard non-employee director compensation. No reason cited beyond board expansion.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $100.70 — A.R:R is negative (-2.1) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Supplier: ethylene single source (German operations) (4.0%). Chart setup: Golden cross, above all MAs, RSI 64, MACD bullish. Prior stop was $97.14. Score 6.2/10, moderate confidence.
Analyst target $85.85 reached (−14.7% from $100.70); no take-profit level is published. Prior stop was $97.14. Stop-loss: $97.14.
Concentration risk — Supplier: ethylene single source (German operations) (4.0%); Analyst target reached - limited upside remaining; Near 52-week high (0.1% away).
Innospec Inc. trades at a P/E of 20.6 (forward 16.3). TrendMatrix value score: 6.8/10. Verdict: Sell.
9 analysts cover IOSP with a consensus score of 4.1/5. Average price target: $101.
What does Innospec Inc. do?Innospec develops, manufactures, and supplies specialty chemicals through three segments — Performance Chemicals, Fuel...
Innospec develops, manufactures, and supplies specialty chemicals through three segments — Performance Chemicals, Fuel Specialties, and Oilfield Services — serving customers in the Americas, Europe, Middle East, Africa, and Asia-Pacific with approximately 2,450 employees in 22 countries. Revenue comes from fuel additives, personal care ingredients, and oilfield drilling chemicals sold to multinational oil companies, personal care manufacturers, and exploration & production companies.